Phosphodiesterase 4-targeted treatments for autoimmune diseases

Advancements in phosphodiesterase (PDE)-targeted therapies have shown promise in recent years for treating patients with a variety of autoimmune diseases. This review summarizes the development of PDE4 inhibitors and the associated literature with a focus on treatments for autoimmune diseases. After...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Neal, Goldminz, Ari M, Kim, Noori, Gottlieb, Alice B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616808/
https://www.ncbi.nlm.nih.gov/pubmed/23557064
http://dx.doi.org/10.1186/1741-7015-11-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616808/
https://www.ncbi.nlm.nih.gov/pubmed/23557064
http://dx.doi.org/10.1186/1741-7015-11-96

Ejemplares similares